Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 2
2004 5
2005 3
2006 3
2007 5
2008 6
2009 7
2010 7
2011 5
2012 2
2013 4
2014 6
2015 5
2016 9
2017 10
2018 5
2019 11
2020 8
2021 8
2022 10
2023 15
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

124 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for s marc fisher
Your search for J Mary Fisher retrieved no results
Tenecteplase versus alteplase in acute ischaemic cerebrovascular events (TRACE-2): a phase 3, multicentre, open-label, randomised controlled, non-inferiority trial.
Wang Y, Li S, Pan Y, Li H, Parsons MW, Campbell BCV, Schwamm LH, Fisher M, Che F, Dai H, Li D, Li R, Wang J, Wang Y, Zhao X, Li Z, Zheng H, Xiong Y, Meng X; TRACE-2 Investigators. Wang Y, et al. Among authors: fisher m. Lancet. 2023 Feb 25;401(10377):645-654. doi: 10.1016/S0140-6736(22)02600-9. Epub 2023 Feb 9. Lancet. 2023. PMID: 36774935 Clinical Trial.
The primary outcome in the modified intention-to-treat population occurred in 439 (62%) of 705 in the tenecteplase group versus 405 (58%) of 696 in the alteplase group (RR 1.07, 95% CI 0.98-1.16). The lower limit of the RR's 95% CI was greater than the non-inferiority marg …
The primary outcome in the modified intention-to-treat population occurred in 439 (62%) of 705 in the tenecteplase group versus 405 (58%) of …
Editor's Correspondence.
Fisher M. Fisher M. Stroke. 2019 Aug;50(8):1945. doi: 10.1161/STROKEAHA.119.026537. Epub 2019 Jul 22. Stroke. 2019. PMID: 31329528 Free article. No abstract available.
Editor's Correspondence.
Fisher M. Fisher M. Stroke. 2018 Sep;49(9):2019. doi: 10.1161/STROKEAHA.118.022851. Stroke. 2018. PMID: 30355014 Free article. No abstract available.
Editor's Correspondence.
Fisher M. Fisher M. Stroke. 2017 Jan;48(1):5. doi: 10.1161/STROKEAHA.116.016340. Epub 2016 Dec 13. Stroke. 2017. PMID: 27965427 No abstract available.
Editor's Correspondence.
Fisher M. Fisher M. Stroke. 2017 Aug;48(8):2039. doi: 10.1161/STROKEAHA.117.018317. Epub 2017 Jul 12. Stroke. 2017. PMID: 28701580 No abstract available.
Remote Ischemic Conditioning for Acute Stroke: The RESIST Randomized Clinical Trial.
Blauenfeldt RA, Hjort N, Valentin JB, Homburg AM, Modrau B, Sandal BF, Gude MF, Hougaard KD, Damgaard D, Poulsen M, Diedrichsen T, Schmitz ML, von Weitzel-Mudersbach P, Christensen AA, Figlewski K, Grove EL, Hreiðarsdóttir MK, Lassesen HM, Wittrock D, Mikkelsen S, Væggemose U, Juelsgaard P, Kirkegaard H, Rostgaard-Knudsen M, Degn N, Vestergaard SB, Damsbo AG, Iversen AB, Mortensen JK, Petersson J, Christensen T, Behrndtz AB, Bøtker HE, Gaist D, Fisher M, Hess DC, Johnsen SP, Simonsen CZ, Andersen G. Blauenfeldt RA, et al. Among authors: fisher m. JAMA. 2023 Oct 3;330(13):1236-1246. doi: 10.1001/jama.2023.16893. JAMA. 2023. PMID: 37787796 Free PMC article. Clinical Trial.
Chronic remote ischaemic conditioning in patients with symptomatic intracranial atherosclerotic stenosis (the RICA trial): a multicentre, randomised, double-blind sham-controlled trial in China.
Hou C, Lan J, Lin Y, Song H, Wang Y, Zhao W, Li S, Meng R, Hao J, Ding Y, Chimowitz MI, Fisher M, Hess DC, Liebeskind DS, Hausenloy DJ, Huang J, Li Z, Han X, Yang J, Zhou J, Chen P, Zhu X, Hu P, Pang H, Chen W, Chen H, Li G, Tao D, Yue W, Gao Z, Ji X; RICA investigators. Hou C, et al. Among authors: fisher m. Lancet Neurol. 2022 Dec;21(12):1089-1098. doi: 10.1016/S1474-4422(22)00335-0. Epub 2022 Oct 27. Lancet Neurol. 2022. PMID: 36354026 Clinical Trial.
Priorities for Advancements in Neuroimaging in the Diagnostic Workup of Acute Stroke.
Samaniego EA, Boltze J, Lyden PD, Hill MD, Campbell BCV, Silva GS, Sheth KN, Fisher M, Hillis AE, Nguyen TN, Carone D, Favilla CG, Deljkich E, Albers GW, Heit JJ, Lansberg MG; XIIth Stroke Treatment Academic Industry Roundtable. Samaniego EA, et al. Among authors: fisher m. Stroke. 2023 Dec;54(12):3190-3201. doi: 10.1161/STROKEAHA.123.044985. Epub 2023 Nov 9. Stroke. 2023. PMID: 37942645 Free article. Review.
124 results